Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey
Background. The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol for DSA-positive recipients. Methods. A Japanese nationwide survey was performed to investigate the cl...
Main Authors: | Nobuhisa Akamatsu, MD, PhD, Kiyoshi Hasegawa, MD, PhD, Seisuke Sakamoto, MD, PhD, Hideki Ohdan, MD, PhD, Ken Nakagawa, MD, PhD, Hiroto Egawa, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2021-08-01
|
Series: | Transplantation Direct |
Online Access: | http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001180 |
Similar Items
-
Successful Desensitization of T cell Flow Cytometry Crossmatch Positive Renal Transplant Recipients Using Plasmapheresis and Super High-Dose Intravenous Immunoglobulin
by: Yoichi Kakuta, MD, PhD, et al.
Published: (2018-01-01) -
Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation—The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation
by: Yohei Yamada, MD, PhD, et al.
Published: (2018-02-01) -
Desensitizing Effect of Cancer Cachexia on Immune Checkpoint Inhibitors in Patients With Advanced NSCLC
by: Taichi Miyawaki, MD, et al.
Published: (2020-06-01) -
Impact of Postoperative Continuous Renal Replacement Therapy in Lung Transplant Recipients
by: Masato Katahira, MD, et al.
Published: (2020-06-01) -
Microvascular Hepatic Artery Anastomosis in Living Donor Liver Transplantation for Erythropoietic Protoporphyria
by: Shuji Yamashita, MD, PhD, et al.
Published: (2020-08-01)